Abstract
Respiratory tract infections were treated with pefloxacin in fifteen patients, who were hospitalized in the intensive care unit and required artificial ventilation. The treatment was successful in ten patients. Development of resistance was observed inStaphylococcus aureus (two times) andPseudomonas aeruginosa (four times). No adverse reactions were seen.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daschner FD, Just HM. In vitro activity of the five quinolone derivatives against no socomial isolates ofStapylococcus andPseudomonas species. Eur J Clin Microbiol 1985;4:72–3.
Hoogkamp-Korstanje JAA. Comparativein vitro activity of five quinolone derivatives and five other antimicrobial agents used in oral therapy. Eur J Clin Microbiol 1984;3:333–8
Lauwers S, Vincken W, Naessens A, Pierard D. Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units. J Antimicrob Chemother 1986;17 suppl. B, 111–5.
Wolff M, Pangon B, Regnier B, Rouveix E, Bauchet J, Vachon F. Traitement de septicemies et endocardites par la pefloxacine Presse Med 1986;15:471–4.
Bertrand A., Janbon F., Jourdan J., Jonquet O., Santoni A., La pefloxacine: experience clinique. Pathol Biol 1985;33:596–9.
Beun GDM, Debrus-Palmas LL, Daniels-Bosman SM, Blijham GH. Chemotherapy with Pefloxacin in neutropenic febrile patients. Poster presented at the International Symposium on New quinolones 1986 in Geneva, Switzerland.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boland, D.M., van Gestel, W.C.F., MacLaren, D.M. et al. Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit. Pharmaceutisch Weekblad Scientific Edition 9 (Suppl 1), S58–S59 (1987). https://doi.org/10.1007/BF02075262
Issue Date:
DOI: https://doi.org/10.1007/BF02075262